CROSSBOW THERAPEUTICS

Serial Number 97087367
606

Registration Progress

Application Filed
Oct 22, 2021
Under Examination
Nov 8, 2022
Approved for Publication
Sep 13, 2022
Published for Opposition
Sep 13, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Feb 15, 2026 48 days
Revival assistance for abandoned trademark

Trademark Image

CROSSBOW THERAPEUTICS

Basic Information

Serial Number
97087367
Filing Date
October 22, 2021
Published for Opposition
September 13, 2022
Abandonment Date
December 15, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 15, 2025
Classes
042

Rights Holder

Crossbow Therapeutics, Inc.

03
Address
1030 Massachusetts Avenue, Suite 210
Cambridge, MA 02138

Ownership History

Crossbow Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Crossbow Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Michael R. Graif

USPTO Deadlines

Next Deadline
48 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
February 15, 2026

Application History

50 events
Date Code Type Description Documents
Dec 15, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 15, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 1, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 1, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 1, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 1, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 17, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 17, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 17, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 13, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 3, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 3, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 4, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 4, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 4, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 6, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 4, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 11, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 11, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 8, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 26, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jun 25, 2023 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Jun 25, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Jun 25, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jun 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 15, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 15, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 12, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 12, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 13, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 13, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 24, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 9, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 8, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 8, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 8, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 8, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 042
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of cancer and immunological diseases; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Additional Information

Pseudo Mark
CROSS BOW THERAPEUTICS

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"